Installation Capable Of Preparing Millions Of Vaccines For Covid 19 Opens In Saskatoon

SASKATUN – A center that can develop up to 40 million doses of COVID-19 vaccine a year has opened in Saskatoon, and officials say it may soon be rolling out vaccines across North America and Europe. The University of Saskatchewan Vaccine and Infectious Diseases Agency has completed construction of the Level 3 Restriction Facility, considered the largest in Canada. It is able to produce vaccines for both humans and animals for dangerous viruses. “We have the ability to work with these pathogens, to discover, to develop new vaccines and then to make them internally, and that saves time and time is very important during a pandemic,” he said on Tuesday. director Volker Gerdts. When COVID-19 was declared a pandemic two years ago by the World Health Organization, such a facility was incomprehensible in Canada, Gerdts said. “During the pandemic, we relied on other countries to make vaccines for us. Now we are changing that and building the capacity … to make vaccines in Canada for Canadians in the future.” If this facility had existed early in the pandemic, lives could have been saved, said Daniel Vandal, Canada’s Federal Minister for Economic Development in the Meadows. “It became very clear early on that we needed some Canadian vaccine production when COVID hit. We went through some difficult years,” Vandal said. Gerdz said talks were under way with several companies in hopes of vaccinating them for COVID-19 in Saskatchewan. Any commercial vaccine made on-site will meet regulatory requirements for sale in North America and the European Union, said Trina Racine, director of vaccine development at the center. “It puts us on a better footing to keep Canadians safe and to play a leading role in North America and the world in vaccine production. And for Saskatchewan, this is a fantastic story. It’s another know-how we can export from this great province.” . ” he said. A handful of COVID-19 bio-manufacturing facilities are currently operating in Canada, but Gerdts said this one in Saskatoon is the first of its kind in the country. For example, he said, biomass at the Montreal facility can only make two types of vaccines. While the center of Saskatoon can produce mRNA, protein and Novavax vaccines, among others. “What sets us apart from theirs is that we are able to vaccinate humans and animals in the same facility,” Gerdz said. He said there is always a risk of diseases and viruses from around the world spreading to North America and the Saskatoon facility is designed to detect them in real time. “So pathogens, in the future that require restriction, we can work with them here. Because this site already operates Canada’s largest containment facility,” Gerdts said. “This facility will allow us to respond quickly to all platforms … and we hope to have a vaccine in less than 100 days.” The center brings exotic animals for research, including a colony of bats, because bats are known to host several viruses. Gerdz said insects and reptiles are also being introduced, as climate change continues to create uncertainty about the spread of diseases transmitted by insect vectors such as mosquitoes, ticks and flies. “It’s great for a research organization like ours to make … vaccines,” Gerdz said. “It is crucial to protect not only the Canadians but also our livestock industries.” This Canadian Press report was first published on June 28, 2022. Mickey Djuric, The Canadian Press

title: “Installation Capable Of Preparing Millions Of Vaccines For Covid 19 Opens In Saskatoon " ShowToc: true date: “2022-12-07” author: “John Zeigler”

SASKATUN – A center that can develop up to 40 million doses of COVID-19 vaccine a year has opened in Saskatoon, and officials say it may soon be rolling out vaccines across North America and Europe. The University of Saskatchewan Vaccine and Infectious Diseases Agency has completed construction of the Level 3 Restriction Facility, considered the largest in Canada. It is able to produce vaccines for both humans and animals for dangerous viruses. “We have the ability to work with these pathogens, to discover, to develop new vaccines and then to make them internally, and that saves time and time is very important during a pandemic,” he said on Tuesday. director Volker Gerdts. When COVID-19 was declared a pandemic two years ago by the World Health Organization, such a facility was incomprehensible in Canada, Gerdts said. “During the pandemic, we relied on other countries to make vaccines for us. Now we are changing that and building the capacity … to make vaccines in Canada for Canadians in the future.” If this facility had existed early in the pandemic, lives could have been saved, said Daniel Vandal, Canada’s Federal Minister for Economic Development in the Meadows. “It became very clear early on that we needed some Canadian vaccine production when COVID hit. We went through some difficult years,” Vandal said. Gerdz said talks were under way with several companies in hopes of vaccinating them for COVID-19 in Saskatchewan. Any commercial vaccine made on-site will meet regulatory requirements for sale in North America and the European Union, said Trina Racine, director of vaccine development at the center. “It puts us on a better footing to keep Canadians safe and to play a leading role in North America and the world in vaccine production. And for Saskatchewan, this is a fantastic story. It’s another know-how we can export from this great province.” . ” he said. A handful of COVID-19 bio-manufacturing facilities are currently operating in Canada, but Gerdts said this one in Saskatoon is the first of its kind in the country. For example, he said, biomass at the Montreal facility can only make two types of vaccines. While the center of Saskatoon can produce mRNA, protein and Novavax vaccines, among others. “What sets us apart from theirs is that we are able to vaccinate humans and animals in the same facility,” Gerdz said. He said there is always a risk of diseases and viruses from around the world spreading to North America and the Saskatoon facility is designed to detect them in real time. “So pathogens, in the future that require restriction, we can work with them here. Because this site already operates Canada’s largest containment facility,” Gerdts said. “This facility will allow us to respond quickly to all platforms … and we hope to have a vaccine in less than 100 days.” The center brings exotic animals for research, including a colony of bats, because bats are known to host several viruses. Gerdz said insects and reptiles are also being introduced, as climate change continues to create uncertainty about the spread of diseases transmitted by insect vectors such as mosquitoes, ticks and flies. “It’s great for a research organization like ours to make … vaccines,” Gerdz said. “It is crucial to protect not only the Canadians but also our livestock industries.” This Canadian Press report was first published on June 28, 2022. Mickey Djuric, The Canadian Press

title: “Installation Capable Of Preparing Millions Of Vaccines For Covid 19 Opens In Saskatoon " ShowToc: true date: “2022-11-21” author: “Karen Anderson”

SASKATUN – A center that can develop up to 40 million doses of COVID-19 vaccine a year has opened in Saskatoon, and officials say it may soon be rolling out vaccines across North America and Europe. The University of Saskatchewan Vaccine and Infectious Diseases Agency has completed construction of the Level 3 Restriction Facility, considered the largest in Canada. It is able to produce vaccines for both humans and animals for dangerous viruses. “We have the ability to work with these pathogens, to discover, to develop new vaccines and then to make them internally, and that saves time and time is very important during a pandemic,” he said on Tuesday. director Volker Gerdts. When COVID-19 was declared a pandemic two years ago by the World Health Organization, such a facility was incomprehensible in Canada, Gerdts said. “During the pandemic, we relied on other countries to make vaccines for us. Now we are changing that and building the capacity … to make vaccines in Canada for Canadians in the future.” If this facility had existed early in the pandemic, lives could have been saved, said Daniel Vandal, Canada’s Federal Minister for Economic Development in the Meadows. “It became very clear early on that we needed some Canadian vaccine production when COVID hit. We went through some difficult years,” Vandal said. Gerdz said talks were under way with several companies in hopes of vaccinating them for COVID-19 in Saskatchewan. Any commercial vaccine made on-site will meet regulatory requirements for sale in North America and the European Union, said Trina Racine, director of vaccine development at the center. “It puts us on a better footing to keep Canadians safe and to play a leading role in North America and the world in vaccine production. And for Saskatchewan, this is a fantastic story. It’s another know-how we can export from this great province.” . ” he said. A handful of COVID-19 bio-manufacturing facilities are currently operating in Canada, but Gerdts said this one in Saskatoon is the first of its kind in the country. For example, he said, biomass at the Montreal facility can only make two types of vaccines. While the center of Saskatoon can produce mRNA, protein and Novavax vaccines, among others. “What sets us apart from theirs is that we are able to vaccinate humans and animals in the same facility,” Gerdz said. He said there is always a risk of diseases and viruses from around the world spreading to North America and the Saskatoon facility is designed to detect them in real time. “So pathogens, in the future that require restriction, we can work with them here. Because this site already operates Canada’s largest containment facility,” Gerdts said. “This facility will allow us to respond quickly to all platforms … and we hope to have a vaccine in less than 100 days.” The center brings exotic animals for research, including a colony of bats, because bats are known to host several viruses. Gerdz said insects and reptiles are also being introduced, as climate change continues to create uncertainty about the spread of diseases transmitted by insect vectors such as mosquitoes, ticks and flies. “It’s great for a research organization like ours to make … vaccines,” Gerdz said. “It is crucial to protect not only the Canadians but also our livestock industries.” This Canadian Press report was first published on June 28, 2022. Mickey Djuric, The Canadian Press